Cargando…

Anticancer evaluation of N-benzoyl-3-allylthiourea as potential antibreast cancer agent through enhances HER-2 expression

Breast cancer with HER-2 overexpression is sensitive to drugs which target the receptor or its kinase activity. Although the anti-HER-2 therapies commonly used have improved patient outcome, resistance usually occurs. In this present study, we investigated a modification of the chemical structure of...

Descripción completa

Detalles Bibliográficos
Autores principales: Widiandani, Tri, Siswandono, Meiyanto, Edy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7784947/
https://www.ncbi.nlm.nih.gov/pubmed/33425698
http://dx.doi.org/10.4103/japtr.JAPTR_77_20

Ejemplares similares